Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Is The Transradial Approach Useful in CTO?

Courtesy of Dr. Carlos Fava.

Is The Transradial Approach Useful in CTO?The transradial approach has been advanced in time, and is being increasingly used in more and more complex angioplasty procedures with the same benefit, compared to the classical femoral approach. As a result, in many high volume centers, this reality has demoted the femoral approach to a few particular procedures.

 

Chronic total occlusions (CTO) are a real challenge and the transradial approach could make them even more so, or it could make them safer. When it came to deciding on the most appropriate approach for CTO PCI, these questions remained unanswered. 

 

The study analyzed 585 CTO cases, 280 (47.8%) involving transradial access and 308 (52.1%) involving femoral access. Populations were similar, with the exception of patients in the femoral group, who more often presented a story of cardiac revascularization surgery. CTO was most frequent in the right coronary artery, followed by the anterior descending artery.

 

Severe calcification and ≥20 mm occlusion was more frequent in the femoral access group. Instead, the transradial group presented a lower J-CTO score. Technical success was similar (74% transradial and 72.5% femoral).

 

After propensity score matching of 187 patients in each group, no differences were found as regards procedural success, but less contrast was used in the femoral access group.

 

Failure was associated to:

  • moderate or severe calcification
  • >20 mm lesions
  • absence of stump
  • ≥3 J-CTO score

 

In patients presenting ≥3 J-CTO, the femoral approach was more successful, compared to the transradial (58.2% vs. 35.7% respectively).

 

The use of a guiding catheter <7F, calcification,>20 mm occlusion length and age were all associated to transradial recanalization failure.

 

Conclusion

CTO recanalization via transradial approach may be feasible in less complex cases. For more challenging complex cases, and especially with severe calcification, the femoral approach showed better results.

 

Editorial Comment

Chronic total occlusions are one of the greatest challenges we currently face. These procedures have been associated with higher complications rates, many of which are access site complications.

 

The transradial approach is a great alternative in some CTO cases, as it has been shown, but there is an important group of patients that still benefit from the femoral approach. We should develop new better devices to be able to use it in all CTO cases.

 

Courtesy of Dr. Carlos Fava. Favaloro Foundation, Buenos Aires, Argentina.

 

Original Title: Transradial Coronary Intervention for Complex Chronic Total Occlusions.

Reference: Yutaka Tanaka et al. J Am Coll cardiol Intv 2017;10:235-43.


Suscríbase a nuestro newsletter semanal

Reciba resúmenes con los últimos artículos científicos

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...